The story of Viagra and its originator, copyright, presents a fascinating picture for prospective investors. While the blockbuster drug initially generated enormous revenues , its exclusivity has lapsed , leading to rival alternatives flooding the market . This reduction in pricing presents a real hurdle for copyright and any company considering a